Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axis
Science Bulletin · 2026-05 · 71 (9) · 2283-2299
DOI: 10.1016/j.scib.2026.04.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Bulletin, 2026-05. Verfasst von Mengya Geng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and …. Hauptthemen laut MEDLINE: Ketoglutaric Acids, Liver, Glutamate Dehydrogenase, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Anhui Provincial Department of Education, University of Science and Technology of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China; School of Clinical Medicine,…
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China; Anhui Provincial Key Laborat…
- School of Pharmacy, University of Queensland, Pharmacy Australia Centre of Excellence, Woolloongabba QLD 4102, Australia.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China. Electronic address: liulx@ustc.edu.…
- Anhui Provincial Key Laboratory of Metabolic Health and Panvascular Diseases, Hefei 230001, China; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China; Anhui Medica…
Förderung
- National Natural Science Foundation of China
- Anhui Provincial Department of Education
- University of Science and Technology of China
Zitieren
APA
Geng, M., Meng, F., Li, H., Sun, L., Sun, X., Ding, Y., Shi, R., Wang, Z., Huang, Y., Wang, J., Liu, Y., Wang, J., Little, P. J., Xu, S., Liu, L., Weng, J., & Luo, S. (2026). Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axis. Science Bulletin, 71(9), 2283-2299. https://doi.org/10.1016/j.scib.2026.04.016
Vancouver
Geng M, Meng F, Li H, Sun L, Sun X, Ding Y, et al. Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axis. Science Bulletin. 2026;71(9):2283-2299. doi:10.1016/j.scib.2026.04.016
BibTeX
@article{Geng2026,
author = {Geng, Mengya and Meng, Fanzheng and Li, Hairui and Sun, Lijie and Sun, Xuedan and Ding, Yu and Shi, Rongdongqing and Wang, Zhihua and Huang, Yabin and Wang, Jizhou and Liu, Yao and Wang, Jiabei and Little, Peter J and Xu, Suowen and Liu, Lianxin and Weng, Jianping and Luo, Sihui},
title = {Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axis},
journal = {Science Bulletin},
year = {2026},
volume = {71},
number = {9},
pages = {2283--2299},
doi = {10.1016/j.scib.2026.04.016}
}
EUVIMED